Form D · Biotechnology
AASTROM BIOSCIENCES INC
Ann Arbor, MI · CIK 0000887359
Offering snapshot reported Mar 23, 2012 · SEC filing
- Reported sold
- $40M Offering amount: $40M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Mar 9, 2012 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 23, 2012 | Initial | $40,001,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $2.2M (estimated)
- Form D file number
- 021-175515
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| MLV & Co. LLC | 150959 |
Source: Form D, filed Mar 23, 2012. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Ronald M. Cresswell | Director |
| Brian D. Gibson | Executive |
| Timothy M. Mayleben | Director, Executive |
| Alan L. Rubino | Director |
| Nelson M. Sims | Director |
| Harold C. Urschel | Director |
| Robert L. Zerbe | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
24 Frank Lloyd Wright Dr, Po Box 376
Ann Arbor, MI, 48106
Ann Arbor, MI, 48106